vs

Side-by-side financial comparison of Arcosa, Inc. (ACA) and AXCELIS TECHNOLOGIES INC (ACLS). Click either name above to swap in a different company.

Arcosa, Inc. is the larger business by last-quarter revenue ($716.7M vs $238.3M, roughly 3.0× AXCELIS TECHNOLOGIES INC). AXCELIS TECHNOLOGIES INC runs the higher net margin — 14.4% vs 7.3%, a 7.1% gap on every dollar of revenue. On growth, Arcosa, Inc. posted the faster year-over-year revenue change (7.6% vs -5.6%). Arcosa, Inc. produced more free cash flow last quarter ($55.8M vs $-8.9M). Over the past eight quarters, Arcosa, Inc.'s revenue compounded faster (9.4% CAGR vs -2.8%).

Arcosa, Inc. is a provider of infrastructure-related products and solutions operating across three core segments: construction, energy, and transportation. It offers products including utility structures, construction aggregates, and transportation components, primarily serving customers across the North American market to support critical infrastructure development projects.

Axcelis Technologies, Inc. is an American company engaging in the design, manufacture, and servicing of capital equipment for the semiconductor manufacturing industry worldwide. It produces ion implantation systems, including high and medium current implanters, and high energy implanters, and curing systems used in the fabrication of semiconductor chips. The company was incorporated in 1995 and is headquartered in Beverly, Massachusetts, United States.

ACA vs ACLS — Head-to-Head

Bigger by revenue
ACA
ACA
3.0× larger
ACA
$716.7M
$238.3M
ACLS
Growing faster (revenue YoY)
ACA
ACA
+13.2% gap
ACA
7.6%
-5.6%
ACLS
Higher net margin
ACLS
ACLS
7.1% more per $
ACLS
14.4%
7.3%
ACA
More free cash flow
ACA
ACA
$64.7M more FCF
ACA
$55.8M
$-8.9M
ACLS
Faster 2-yr revenue CAGR
ACA
ACA
Annualised
ACA
9.4%
-2.8%
ACLS

Income Statement — Q4 2025 vs Q4 2025

Metric
ACA
ACA
ACLS
ACLS
Revenue
$716.7M
$238.3M
Net Profit
$52.1M
$34.3M
Gross Margin
22.9%
47.0%
Operating Margin
11.0%
15.2%
Net Margin
7.3%
14.4%
Revenue YoY
7.6%
-5.6%
Net Profit YoY
776.6%
-31.3%
EPS (diluted)
$1.06
$1.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACA
ACA
ACLS
ACLS
Q4 25
$716.7M
$238.3M
Q3 25
$797.8M
$213.6M
Q2 25
$736.9M
$194.5M
Q1 25
$632.0M
$192.6M
Q4 24
$666.2M
$252.4M
Q3 24
$640.4M
$256.6M
Q2 24
$664.7M
$256.5M
Q1 24
$598.6M
$252.4M
Net Profit
ACA
ACA
ACLS
ACLS
Q4 25
$52.1M
$34.3M
Q3 25
$73.0M
$26.0M
Q2 25
$59.7M
$31.4M
Q1 25
$23.6M
$28.6M
Q4 24
$-7.7M
$50.0M
Q3 24
$16.6M
$48.6M
Q2 24
$45.6M
$50.9M
Q1 24
$39.2M
$51.6M
Gross Margin
ACA
ACA
ACLS
ACLS
Q4 25
22.9%
47.0%
Q3 25
24.1%
41.6%
Q2 25
22.5%
44.9%
Q1 25
19.8%
46.1%
Q4 24
19.3%
46.0%
Q3 24
21.3%
42.9%
Q2 24
20.8%
43.8%
Q1 24
18.6%
46.0%
Operating Margin
ACA
ACA
ACLS
ACLS
Q4 25
11.0%
15.2%
Q3 25
14.1%
11.7%
Q2 25
12.9%
14.9%
Q1 25
8.8%
15.1%
Q4 24
6.5%
21.6%
Q3 24
5.3%
18.3%
Q2 24
10.1%
20.6%
Q1 24
8.9%
22.4%
Net Margin
ACA
ACA
ACLS
ACLS
Q4 25
7.3%
14.4%
Q3 25
9.2%
12.2%
Q2 25
8.1%
16.1%
Q1 25
3.7%
14.8%
Q4 24
-1.2%
19.8%
Q3 24
2.6%
18.9%
Q2 24
6.9%
19.8%
Q1 24
6.5%
20.4%
EPS (diluted)
ACA
ACA
ACLS
ACLS
Q4 25
$1.06
$1.11
Q3 25
$1.48
$0.83
Q2 25
$1.22
$0.98
Q1 25
$0.48
$0.88
Q4 24
$-0.16
$1.54
Q3 24
$0.34
$1.49
Q2 24
$0.93
$1.55
Q1 24
$0.80
$1.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACA
ACA
ACLS
ACLS
Cash + ST InvestmentsLiquidity on hand
$214.6M
$374.3M
Total DebtLower is stronger
$1.5B
Stockholders' EquityBook value
$2.6B
$1.0B
Total Assets
$5.0B
$1.4B
Debt / EquityLower = less leverage
0.57×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACA
ACA
ACLS
ACLS
Q4 25
$214.6M
$374.3M
Q3 25
$220.0M
$449.6M
Q2 25
$189.7M
$549.8M
Q1 25
$167.9M
$587.1M
Q4 24
$187.3M
$571.3M
Q3 24
$756.8M
$579.4M
Q2 24
$103.7M
$548.3M
Q1 24
$176.5M
$530.2M
Total Debt
ACA
ACA
ACLS
ACLS
Q4 25
$1.5B
Q3 25
$1.6B
Q2 25
$1.7B
Q1 25
$1.7B
Q4 24
$1.7B
Q3 24
$1.2B
Q2 24
$699.9M
Q1 24
$600.6M
Stockholders' Equity
ACA
ACA
ACLS
ACLS
Q4 25
$2.6B
$1.0B
Q3 25
$2.6B
$1.0B
Q2 25
$2.5B
$1.0B
Q1 25
$2.5B
$1.0B
Q4 24
$2.4B
$1.0B
Q3 24
$2.4B
$975.6M
Q2 24
$2.4B
$934.9M
Q1 24
$2.4B
$901.7M
Total Assets
ACA
ACA
ACLS
ACLS
Q4 25
$5.0B
$1.4B
Q3 25
$5.1B
$1.4B
Q2 25
$5.0B
$1.3B
Q1 25
$4.9B
$1.3B
Q4 24
$4.9B
$1.3B
Q3 24
$4.4B
$1.3B
Q2 24
$3.8B
$1.3B
Q1 24
$3.7B
$1.3B
Debt / Equity
ACA
ACA
ACLS
ACLS
Q4 25
0.57×
Q3 25
0.61×
Q2 25
0.67×
Q1 25
0.68×
Q4 24
0.69×
Q3 24
0.51×
Q2 24
0.29×
Q1 24
0.25×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACA
ACA
ACLS
ACLS
Operating Cash FlowLast quarter
$120.0M
$-6.6M
Free Cash FlowOCF − Capex
$55.8M
$-8.9M
FCF MarginFCF / Revenue
7.8%
-3.7%
Capex IntensityCapex / Revenue
9.0%
1.0%
Cash ConversionOCF / Net Profit
2.30×
-0.19×
TTM Free Cash FlowTrailing 4 quarters
$175.5M
$107.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACA
ACA
ACLS
ACLS
Q4 25
$120.0M
$-6.6M
Q3 25
$160.6M
$45.4M
Q2 25
$61.2M
$39.7M
Q1 25
$-700.0K
$39.8M
Q4 24
$248.2M
$12.8M
Q3 24
$135.0M
$45.7M
Q2 24
$38.3M
$40.1M
Q1 24
$80.5M
$42.2M
Free Cash Flow
ACA
ACA
ACLS
ACLS
Q4 25
$55.8M
$-8.9M
Q3 25
$121.0M
$43.3M
Q2 25
$33.4M
$37.7M
Q1 25
$-34.7M
$34.8M
Q4 24
$194.9M
$8.1M
Q3 24
$100.6M
$41.8M
Q2 24
$-9.3M
$38.1M
Q1 24
$26.1M
$40.6M
FCF Margin
ACA
ACA
ACLS
ACLS
Q4 25
7.8%
-3.7%
Q3 25
15.2%
20.3%
Q2 25
4.5%
19.4%
Q1 25
-5.5%
18.1%
Q4 24
29.3%
3.2%
Q3 24
15.7%
16.3%
Q2 24
-1.4%
14.8%
Q1 24
4.4%
16.1%
Capex Intensity
ACA
ACA
ACLS
ACLS
Q4 25
9.0%
1.0%
Q3 25
5.0%
0.9%
Q2 25
3.8%
1.0%
Q1 25
5.4%
2.6%
Q4 24
8.0%
1.8%
Q3 24
5.4%
1.5%
Q2 24
7.2%
0.8%
Q1 24
9.1%
0.6%
Cash Conversion
ACA
ACA
ACLS
ACLS
Q4 25
2.30×
-0.19×
Q3 25
2.20×
1.75×
Q2 25
1.03×
1.27×
Q1 25
-0.03×
1.39×
Q4 24
0.26×
Q3 24
8.13×
0.94×
Q2 24
0.84×
0.79×
Q1 24
2.05×
0.82×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACA
ACA

Engineered Structures$301.1M42%
Total Construction Materials$276.8M39%
Specialty Materials And Asphalt$110.2M15%
Construction Site Support$28.6M4%

ACLS
ACLS

Products$224.6M94%
Services$13.7M6%

Related Comparisons